Wire · opportunities
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 18 August 2026 · Fusion42 review
Co-Diagnostics' Chief Commercialization Officer participated in a Utah-based medical devices roundtable discussing industry innovations, highlighting the company's FDA 510(k) submission for its PCR Flu A/B & RSV multiplex test on the Co-Dx PCR Pro® instrument aimed at point-of-care diagnostics.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You face a near-term regulatory gate for your molecular diagnostic platform with Co-Diagnostics advancing FDA clearance. Prepare now for commercial roll-out if your product is similar or complementary to their point-of-care PCR tests.
◆ Coverage
1 source · 18 Aug 2026
◆ Related on Wire
◆ Topics